APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alzheimer’s Therapeutic

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alzheimer’s Therapeutic Industry Growth and Trends Forecast to 2032

Report ID 173962530122 December 2025100 pages

Choose your research edition.

Industry ResearchAlzheimer’s Therapeutic Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Alzheimer’s Therapeutic Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Alzheimer’s Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alzheimer’s Therapeutic Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alzheimer’s Therapeutic Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Alzheimer’s Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alzheimer’s Therapeutic include Takeda Pharmaceutical Company Ltd, Merck & Co, F. Hoffman Le Roche, Eli Lilly, Inc, Pfizer Inc, Novartis International AG, H. Lundbeck A/S, Biotie Therapies and Axovant Sciences Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alzheimer’s Therapeutic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alzheimer’s Therapeutic market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alzheimer’s Therapeutic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alzheimer’s Therapeutic.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alzheimer’s Therapeutic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alzheimer’s Therapeutic Market by Company

Takeda Pharmaceutical Company Ltd

Merck & Co

F. Hoffman Le Roche

Eli Lilly, Inc

Pfizer Inc

Novartis International AG

H. Lundbeck A/S

Biotie Therapies

Axovant Sciences Ltd

Astra Zeneca plc

Acadia Pharmaceuticals, Inc

Alzheimer’s Therapeutic Segment by Type

Rivastigmine

Galantamine Hydrobromide

Donepezil Hydrochloride

Memantine Hydrochloride

Alzheimer’s Therapeutic Segment by Application

Hospitals

Clinic

Other

Alzheimer’s Therapeutic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer’s Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alzheimer’s Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer’s Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alzheimer’s Therapeutic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alzheimer’s Therapeutic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rivastigmine Table 2. Major Company of Galantamine Hydrobromide Table 3. Major Company of Donepezil Hydrochloride Table 4. Major Company of Memantine Hydrochloride Table 5. Global Alzheimer’s Therapeutic Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 7. Global Alzheimer’s Therapeutic Sales Market Share in Volume by Type (2021-2026) Table 8. Global Alzheimer’s Therapeutic Sales by Type (2021-2026) & (US$ Million) Table 9. Global Alzheimer’s Therapeutic Sales Market Share in Value by Type (2021-2026) Table 10. Global Alzheimer’s Therapeutic Price by Type (2021-2026) & (US$/unit) Table 11. Global Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 12. Global Alzheimer’s Therapeutic Sales Market Share in Volume by Type (2027-2032) Table 13. Global Alzheimer’s Therapeutic Sales by Type (2027-2032) & (US$ Million) Table 14. Global Alzheimer’s Therapeutic Sales Market Share in Value by Type (2027-2032) Table 15. Global Alzheimer’s Therapeutic Price by Type (2027-2032) & (US$/unit) Table 16. North America Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 17. North America Alzheimer’s Therapeutic Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 19. Europe Alzheimer’s Therapeutic Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Alzheimer’s Therapeutic Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 23. Latin America Alzheimer’s Therapeutic Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Alzheimer’s Therapeutic Sales by Type (2021-2026) & (US$ Million) Table 26. Alzheimer’s Therapeutic Industry Trends Table 27. Alzheimer’s Therapeutic Industry Drivers Table 28. Alzheimer’s Therapeutic Industry Opportunities and Challenges Table 29. Alzheimer’s Therapeutic Industry Restraints Table 30. Global Alzheimer’s Therapeutic Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Alzheimer’s Therapeutic Revenue Market Share by Company (2021-2026) Table 32. Global Alzheimer’s Therapeutic Sales by Company (2021-2026) & (k units) Table 33. Global Alzheimer’s Therapeutic Sales Share by Company (2021-2026) Table 34. Global Alzheimer’s Therapeutic Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Alzheimer’s Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Alzheimer’s Therapeutic Major Company Production Sites and Headquarters Table 37. Global Alzheimer’s Therapeutic Company, Product Type & Application Table 38. Global Alzheimer’s Therapeutic Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Alzheimer’s Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Alzheimer’s Therapeutic Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Alzheimer’s Therapeutic Sales by Region (2021-2026) & (k units) Table 43. Global Alzheimer’s Therapeutic Sales Market Share in Volume by Region (2021-2026) Table 44. Global Alzheimer’s Therapeutic Sales by Region (2021-2026) & (US$ Million) Table 45. Global Alzheimer’s Therapeutic Sales Market Share in Value by Region (2021-2026) Table 46. Global Alzheimer’s Therapeutic Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Alzheimer’s Therapeutic Sales by Region (2027-2032) & (k units) Table 48. Global Alzheimer’s Therapeutic Sales Market Share in Volume by Region (2027-2032) Table 49. Global Alzheimer’s Therapeutic Sales by Region (2027-2032) & (US$ Million) Table 50. Global Alzheimer’s Therapeutic Sales Market Share in Value by Region (2027-2032) Table 51. Global Alzheimer’s Therapeutic Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Alzheimer’s Therapeutic Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 54. Global Alzheimer’s Therapeutic Sales Market Share in Volume by Application (2021-2026) Table 55. Global Alzheimer’s Therapeutic Sales by Application (2021-2026) & (US$ Million) Table 56. Global Alzheimer’s Therapeutic Sales Market Share in Value by Application (2021-2026) Table 57. Global Alzheimer’s Therapeutic Price by Application (2021-2026) & (US$/unit) Table 58. Global Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 59. Global Alzheimer’s Therapeutic Sales Market Share in Volume by Application (2027-2032) Table 60. Global Alzheimer’s Therapeutic Sales by Application (2027-2032) & (US$ Million) Table 61. Global Alzheimer’s Therapeutic Sales Market Share in Value by Application (2027-2032) Table 62. Global Alzheimer’s Therapeutic Price by Application (2027-2032) & (US$/unit) Table 63. North America Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 64. North America Alzheimer’s Therapeutic Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 66. Europe Alzheimer’s Therapeutic Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Alzheimer’s Therapeutic Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 70. Latin America Alzheimer’s Therapeutic Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Alzheimer’s Therapeutic Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Pharmaceutical Company Ltd Company Information Table 74. Takeda Pharmaceutical Company Ltd Business Overview Table 75. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product Portfolio Table 77. Takeda Pharmaceutical Company Ltd Recent Development Table 78. Merck & Co Company Information Table 79. Merck & Co Business Overview Table 80. Merck & Co Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck & Co Alzheimer’s Therapeutic Product Portfolio Table 82. Merck & Co Recent Development Table 83. F. Hoffman Le Roche Company Information Table 84. F. Hoffman Le Roche Business Overview Table 85. F. Hoffman Le Roche Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. F. Hoffman Le Roche Alzheimer’s Therapeutic Product Portfolio Table 87. F. Hoffman Le Roche Recent Development Table 88. Eli Lilly, Inc Company Information Table 89. Eli Lilly, Inc Business Overview Table 90. Eli Lilly, Inc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Eli Lilly, Inc Alzheimer’s Therapeutic Product Portfolio Table 92. Eli Lilly, Inc Recent Development Table 93. Pfizer Inc Company Information Table 94. Pfizer Inc Business Overview Table 95. Pfizer Inc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Pfizer Inc Alzheimer’s Therapeutic Product Portfolio Table 97. Pfizer Inc Recent Development Table 98. Novartis International AG Company Information Table 99. Novartis International AG Business Overview Table 100. Novartis International AG Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Novartis International AG Alzheimer’s Therapeutic Product Portfolio Table 102. Novartis International AG Recent Development Table 103. H. Lundbeck A/S Company Information Table 104. H. Lundbeck A/S Business Overview Table 105. H. Lundbeck A/S Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. H. Lundbeck A/S Alzheimer’s Therapeutic Product Portfolio Table 107. H. Lundbeck A/S Recent Development Table 108. Biotie Therapies Company Information Table 109. Biotie Therapies Business Overview Table 110. Biotie Therapies Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Biotie Therapies Alzheimer’s Therapeutic Product Portfolio Table 112. Biotie Therapies Recent Development Table 113. Axovant Sciences Ltd Company Information Table 114. Axovant Sciences Ltd Business Overview Table 115. Axovant Sciences Ltd Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Axovant Sciences Ltd Alzheimer’s Therapeutic Product Portfolio Table 117. Axovant Sciences Ltd Recent Development Table 118. Astra Zeneca plc Company Information Table 119. Astra Zeneca plc Business Overview Table 120. Astra Zeneca plc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Astra Zeneca plc Alzheimer’s Therapeutic Product Portfolio Table 122. Astra Zeneca plc Recent Development Table 123. Acadia Pharmaceuticals, Inc Company Information Table 124. Acadia Pharmaceuticals, Inc Business Overview Table 125. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product Portfolio Table 127. Acadia Pharmaceuticals, Inc Recent Development Table 128. North America Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. North America Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 130. North America Alzheimer’s Therapeutic Sales Market Share by Country (2021-2026) Table 131. North America Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032) & (k units) Table 132. North America Alzheimer’s Therapeutic Sales Market Share Forecast by Country (2027-2032) Table 133. North America Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Alzheimer’s Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Alzheimer’s Therapeutic Market Share by Country (2021-2026) Table 136. North America Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Alzheimer’s Therapeutic Market Share Forecast by Country (2027-2032) Table 138. Europe Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Europe Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 140. Europe Alzheimer’s Therapeutic Sales Market Share by Country (2021-2026) Table 141. Europe Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032) & (k units) Table 142. Europe Alzheimer’s Therapeutic Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Alzheimer’s Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Alzheimer’s Therapeutic Market Share by Country (2021-2026) Table 146. Europe Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Alzheimer’s Therapeutic Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 150. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032) & (k units) Table 152. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Alzheimer’s Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Alzheimer’s Therapeutic Market Share by Country (2021-2026) Table 156. Asia-Pacific Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Alzheimer’s Therapeutic Market Share Forecast by Country (2027-2032) Table 158. Latin America Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Latin America Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 160. Latin America Alzheimer’s Therapeutic Sales Market Share by Country (2021-2026) Table 161. Latin America Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032) & (k units) Table 162. Latin America Alzheimer’s Therapeutic Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Alzheimer’s Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Alzheimer’s Therapeutic Market Share by Country (2021-2026) Table 166. Latin America Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Alzheimer’s Therapeutic Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 170. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032) & (k units) Table 172. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Alzheimer’s Therapeutic Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Alzheimer’s Therapeutic Market Share by Country (2021-2026) Table 176. Middle East and Africa Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Alzheimer’s Therapeutic Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Alzheimer’s Therapeutic Distributors List Table 181. Alzheimer’s Therapeutic Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Alzheimer’s Therapeutic Image Figure 2. Global Alzheimer’s Therapeutic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alzheimer’s Therapeutic Market Size (2021-2032) & (US$ Million) Figure 4. Global Alzheimer’s Therapeutic Sales (2021-2032) & (k units) Figure 5. Rivastigmine Image Figure 6. Global Rivastigmine Sales YoY Growth (2021-2032) & (k units) Figure 7. Galantamine Hydrobromide Image Figure 8. Global Galantamine Hydrobromide Sales YoY Growth (2021-2032) & (k units) Figure 9. Donepezil Hydrochloride Image Figure 10. Global Donepezil Hydrochloride Sales YoY Growth (2021-2032) & (k units) Figure 11. Memantine Hydrochloride Image Figure 12. Global Memantine Hydrochloride Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Alzheimer’s Therapeutic Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Alzheimer’s Therapeutic Market Share by Type 2025 VS 2032 Figure 15. North America Alzheimer’s Therapeutic Sales Market Share in Volume by Type in 2025 Figure 16. North America Alzheimer’s Therapeutic Sales Market Share in Value by Type in 2025 Figure 17. Europe Alzheimer’s Therapeutic Sales Market Share in Volume by Type in 2025 Figure 18. Europe Alzheimer’s Therapeutic Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share in Value by Type in 2025 Figure 21. Latin America Alzheimer’s Therapeutic Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Alzheimer’s Therapeutic Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Alzheimer’s Therapeutic Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Alzheimer’s Therapeutic Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Alzheimer’s Therapeutic Market Share by Application 2025 VS 2032 Figure 35. North America Alzheimer’s Therapeutic Sales Market Share in Volume by Application in 2025 Figure 36. North America Alzheimer’s Therapeutic Sales Market Share in Value by Application in 2025 Figure 37. Europe Alzheimer’s Therapeutic Sales Market Share in Volume by Application in 2025 Figure 38. Europe Alzheimer’s Therapeutic Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share in Value by Application in 2025 Figure 41. Latin America Alzheimer’s Therapeutic Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Alzheimer’s Therapeutic Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share in Value by Application in 2025 Figure 45. North America Alzheimer’s Therapeutic Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Alzheimer’s Therapeutic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Alzheimer’s Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Alzheimer’s Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Alzheimer’s Therapeutic Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Alzheimer’s Therapeutic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Alzheimer’s Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Alzheimer’s Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Alzheimer’s Therapeutic Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Alzheimer’s Therapeutic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Alzheimer’s Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Alzheimer’s Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Alzheimer’s Therapeutic Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Alzheimer’s Therapeutic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Alzheimer’s Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Alzheimer’s Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Alzheimer’s Therapeutic Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Alzheimer’s Therapeutic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Alzheimer’s Therapeutic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Alzheimer’s Therapeutic Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Alzheimer’s Therapeutic Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Alzheimer’s Therapeutic Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Rivastigmine
  • Galantamine Hydrobromide
  • Donepezil Hydrochloride
  • Memantine Hydrochloride
Applications
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Merck & Co
  • F. Hoffman Le Roche
  • Eli Lilly, Inc
  • Pfizer Inc
  • Novartis International AG
  • H. Lundbeck A/S
  • Biotie Therapies
  • Axovant Sciences Ltd
  • Astra Zeneca plc
  • Acadia Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alzheimer’s Therapeutic Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alzheimer’s Therapeutic Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alzheimer’s Therapeutic Market by Type
  6. 1.3.1 Rivastigmine
  7. 1.3.2 Galantamine Hydrobromide
  8. 1.3.3 Donepezil Hydrochloride
  9. 1.3.4 Memantine Hydrochloride
  10. 1.4 Global Alzheimer’s Therapeutic Market Size by Type
  11. 1.4.1 Global Alzheimer’s Therapeutic Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Alzheimer’s Therapeutic Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Alzheimer’s Therapeutic Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Alzheimer’s Therapeutic Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Alzheimer’s Therapeutic Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Alzheimer’s Therapeutic Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Alzheimer’s Therapeutic Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Alzheimer’s Therapeutic Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alzheimer’s Therapeutic Industry Trends
  2. 2.2 Alzheimer’s Therapeutic Industry Drivers
  3. 2.3 Alzheimer’s Therapeutic Industry Opportunities and Challenges
  4. 2.4 Alzheimer’s Therapeutic Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alzheimer’s Therapeutic Revenue (2021-2026)
  2. 3.2 Global Top Players by Alzheimer’s Therapeutic Sales (2021-2026)
  3. 3.3 Global Top Players by Alzheimer’s Therapeutic Price (2021-2026)
  4. 3.4 Global Alzheimer’s Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alzheimer’s Therapeutic Major Company Production Sites & Headquarters
  6. 3.6 Global Alzheimer’s Therapeutic Company, Product Type & Application
  7. 3.7 Global Alzheimer’s Therapeutic Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alzheimer’s Therapeutic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alzheimer’s Therapeutic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alzheimer’s Therapeutic Tier 1, Tier 2, and Tier 3
4 Alzheimer’s Therapeutic Regional Status and Outlook
  1. 4.1 Global Alzheimer’s Therapeutic Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alzheimer’s Therapeutic Historic Market Size by Region
  3. 4.2.1 Global Alzheimer’s Therapeutic Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alzheimer’s Therapeutic Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alzheimer’s Therapeutic Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alzheimer’s Therapeutic Forecasted Market Size by Region
  7. 4.3.1 Global Alzheimer’s Therapeutic Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alzheimer’s Therapeutic Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alzheimer’s Therapeutic Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alzheimer’s Therapeutic by Application
  1. 5.1 Alzheimer’s Therapeutic Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Alzheimer’s Therapeutic Market Size by Application
  6. 5.2.1 Global Alzheimer’s Therapeutic Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Alzheimer’s Therapeutic Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Alzheimer’s Therapeutic Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Alzheimer’s Therapeutic Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Alzheimer’s Therapeutic Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Alzheimer’s Therapeutic Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Alzheimer’s Therapeutic Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Alzheimer’s Therapeutic Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company Ltd
  2. 6.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 6.2 Merck & Co
  8. 6.2.1 Merck & Co Company Information
  9. 6.2.2 Merck & Co Business Overview
  10. 6.2.3 Merck & Co Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co Alzheimer’s Therapeutic Product Portfolio
  12. 6.2.5 Merck & Co Recent Developments
  13. 6.3 F. Hoffman Le Roche
  14. 6.3.1 F. Hoffman Le Roche Company Information
  15. 6.3.2 F. Hoffman Le Roche Business Overview
  16. 6.3.3 F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 F. Hoffman Le Roche Alzheimer’s Therapeutic Product Portfolio
  18. 6.3.5 F. Hoffman Le Roche Recent Developments
  19. 6.4 Eli Lilly, Inc
  20. 6.4.1 Eli Lilly, Inc Company Information
  21. 6.4.2 Eli Lilly, Inc Business Overview
  22. 6.4.3 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly, Inc Alzheimer’s Therapeutic Product Portfolio
  24. 6.4.5 Eli Lilly, Inc Recent Developments
  25. 6.5 Pfizer Inc
  26. 6.5.1 Pfizer Inc Company Information
  27. 6.5.2 Pfizer Inc Business Overview
  28. 6.5.3 Pfizer Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Inc Alzheimer’s Therapeutic Product Portfolio
  30. 6.5.5 Pfizer Inc Recent Developments
  31. 6.6 Novartis International AG
  32. 6.6.1 Novartis International AG Company Information
  33. 6.6.2 Novartis International AG Business Overview
  34. 6.6.3 Novartis International AG Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis International AG Alzheimer’s Therapeutic Product Portfolio
  36. 6.6.5 Novartis International AG Recent Developments
  37. 6.7 H. Lundbeck A/S
  38. 6.7.1 H. Lundbeck A/S Company Information
  39. 6.7.2 H. Lundbeck A/S Business Overview
  40. 6.7.3 H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 H. Lundbeck A/S Alzheimer’s Therapeutic Product Portfolio
  42. 6.7.5 H. Lundbeck A/S Recent Developments
  43. 6.8 Biotie Therapies
  44. 6.8.1 Biotie Therapies Company Information
  45. 6.8.2 Biotie Therapies Business Overview
  46. 6.8.3 Biotie Therapies Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biotie Therapies Alzheimer’s Therapeutic Product Portfolio
  48. 6.8.5 Biotie Therapies Recent Developments
  49. 6.9 Axovant Sciences Ltd
  50. 6.9.1 Axovant Sciences Ltd Company Information
  51. 6.9.2 Axovant Sciences Ltd Business Overview
  52. 6.9.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Axovant Sciences Ltd Alzheimer’s Therapeutic Product Portfolio
  54. 6.9.5 Axovant Sciences Ltd Recent Developments
  55. 6.10 Astra Zeneca plc
  56. 6.10.1 Astra Zeneca plc Company Information
  57. 6.10.2 Astra Zeneca plc Business Overview
  58. 6.10.3 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Astra Zeneca plc Alzheimer’s Therapeutic Product Portfolio
  60. 6.10.5 Astra Zeneca plc Recent Developments
  61. 6.11 Acadia Pharmaceuticals, Inc
  62. 6.11.1 Acadia Pharmaceuticals, Inc Company Information
  63. 6.11.2 Acadia Pharmaceuticals, Inc Business Overview
  64. 6.11.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product Portfolio
  66. 6.11.5 Acadia Pharmaceuticals, Inc Recent Developments
7 North America by Country
  1. 7.1 North America Alzheimer’s Therapeutic Sales by Country
  2. 7.1.1 North America Alzheimer’s Therapeutic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alzheimer’s Therapeutic Sales by Country (2021-2026)
  4. 7.1.3 North America Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alzheimer’s Therapeutic Market Size by Country
  6. 7.2.1 North America Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alzheimer’s Therapeutic Market Size by Country (2021-2026)
  8. 7.2.3 North America Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alzheimer’s Therapeutic Sales by Country
  2. 8.1.1 Europe Alzheimer’s Therapeutic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alzheimer’s Therapeutic Sales by Country (2021-2026)
  4. 8.1.3 Europe Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alzheimer’s Therapeutic Market Size by Country
  6. 8.2.1 Europe Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alzheimer’s Therapeutic Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alzheimer’s Therapeutic Sales by Country
  2. 9.1.1 Asia-Pacific Alzheimer’s Therapeutic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alzheimer’s Therapeutic Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alzheimer’s Therapeutic Market Size by Country
  6. 9.2.1 Asia-Pacific Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alzheimer’s Therapeutic Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alzheimer’s Therapeutic Sales by Country
  2. 10.1.1 South America Alzheimer’s Therapeutic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alzheimer’s Therapeutic Sales by Country (2021-2026)
  4. 10.1.3 South America Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alzheimer’s Therapeutic Market Size by Country
  6. 10.2.1 South America Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alzheimer’s Therapeutic Market Size by Country (2021-2026)
  8. 10.2.3 South America Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alzheimer’s Therapeutic Sales by Country
  2. 11.1.1 Middle East and Africa Alzheimer’s Therapeutic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alzheimer’s Therapeutic Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alzheimer’s Therapeutic Market Size by Country
  6. 11.2.1 Middle East and Africa Alzheimer’s Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alzheimer’s Therapeutic Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alzheimer’s Therapeutic Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alzheimer’s Therapeutic Value Chain Analysis
  2. 12.1.1 Alzheimer’s Therapeutic Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alzheimer’s Therapeutic Production Mode & Process
  7. 12.2 Alzheimer’s Therapeutic Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alzheimer’s Therapeutic Distributors
  10. 12.2.3 Alzheimer’s Therapeutic Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst